Latest filing published 17 Jan 2020 for Deciphera Pharmaceuticals, Inc., €43k.
Filing timeline
BuySaleInsider track record
Christopher John Morl: trading record in brief
All filings by Christopher John Morl on record concern Deciphera Pharmaceuticals, Inc. Between 3 December 2019 and 16 January 2020, the trades on record add up to 23 filings.
On the market, this insider has only sold: 14 sales, €4.7M in total. Other entries cover 9 option exercises. So far in 2020, the count stands at no purchases and 10 sales.
The latest filing, published on 17 January 2020, reports an open-market sale of €177k in Deciphera Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Christopher John Morl
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,023 shares@ US$3.950.9% of flowCommon StockSEC:0001209191-20-003949:0
- 12,023 shares@ US$65.2314.2% of flowCommon StockSEC:0001209191-20-003949:1
- 3,011 shares@ US$3.950.2% of flowCommon StockSEC:0001209191-20-003949:2
- 3,011 shares@ US$65.403.5% of flowCommon StockSEC:0001209191-20-003949:3
- 1,650 shares@ US$3.950.1% of flowCommon StockSEC:0001209191-20-002708:0
- 1,650 shares@ US$60.021.8% of flowCommon StockSEC:0001209191-20-002708:1
- 12,281 shares@ US$3.950.9% of flowCommon StockSEC:0001209191-20-002708:2
- 12,281 shares@ US$60.1213.3% of flowCommon StockSEC:0001209191-20-002708:3
- 16,137 shares@ US$3.951.1% of flowCommon StockSEC:0001209191-20-001759:0
- 8,505 shares@ US$57.748.8% of flowCommon StockSEC:0001209191-20-001759:1
- 3,529 shares@ US$58.383.7% of flowCommon StockSEC:0001209191-20-001759:2
- 2,103 shares@ US$59.482.2% of flowCommon StockSEC:0001209191-20-001759:3
- 800 shares@ US$60.580.9% of flowCommon StockSEC:0001209191-20-001759:4
- 800 shares@ US$61.580.9% of flowCommon StockSEC:0001209191-20-001759:5
- 400 shares@ US$62.250.4% of flowCommon StockSEC:0001209191-20-001759:6
- 15,034 shares@ US$3.951.1% of flowCommon StockSEC:0001209191-19-060446:0
- 15,034 shares@ US$60.0016.3% of flowCommon StockSEC:0001209191-19-060446:1
- 3,387 shares@ US$3.950.2% of flowCommon StockSEC:0001209191-19-060041:0
- 3,387 shares@ US$55.003.4% of flowCommon StockSEC:0001209191-19-060041:1
- 11,647 shares@ US$3.950.8% of flowCommon StockSEC:0001209191-19-060041:2
- 11,647 shares@ US$55.0011.6% of flowCommon StockSEC:0001209191-19-060041:3
- 15,034 shares0Common StockSEC:0001209191-19-059293:0
- 15,034 shares@ US$50.0013.6% of flowCommon StockSEC:0001209191-19-059293:1
23 of 23 declarations
